Kestra Medical Technologies (NASDAQ:KMTS) Shares Down 7.5% - What's Next?

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) dropped 7.5% during trading on Monday . The stock traded as low as $21.96 and last traded at $21.96. Approximately 96,719 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 231,238 shares. The stock had previously closed at $23.75.

Analyst Ratings Changes

KMTS has been the topic of several analyst reports. Piper Sandler initiated coverage on Kestra Medical Technologies in a report on Monday, March 31st. They set an "overweight" rating and a $27.00 price objective on the stock. Bank of America initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $30.00 price objective on the stock. The Goldman Sachs Group decreased their target price on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 16th. Wells Fargo & Company began coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $28.00 price target on the stock. Finally, Stifel Nicolaus initiated coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 price objective for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $27.50.

Kestra Medical Technologies Stock Performance

The stock's fifty day moving average price is $23.60.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last announced its quarterly earnings data on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.61). During the same period in the previous year, the business posted ($1.18) earnings per share.

Institutional Trading of Kestra Medical Technologies

Several hedge funds have recently added to or reduced their stakes in KMTS. Brown Advisory Inc. bought a new stake in shares of Kestra Medical Technologies in the first quarter valued at about $13,716,000. Jennison Associates LLC bought a new stake in Kestra Medical Technologies in the first quarter valued at about $1,869,000. Finally, Caas Capital Management LP acquired a new position in shares of Kestra Medical Technologies in the 1st quarter worth approximately $1,470,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.